Fate Therapeutics Aktie
1,01
EUR
+0,02
EUR
+1,84
%
1,16
USD
-0,10
USD
-7,94
%
Werbung
Fate Therapeutics Aktie Analyse
09.08.19 | Fate Therapeutics Buy | BTIG Research | |
22.07.19 | Fate Therapeutics Overweight | Cantor Fitzgerald | |
12.07.19 | Fate Therapeutics Outperform | Oppenheimer & Co. Inc. | |
12.10.17 | Fate Therapeutics Buy | H.C. Wainwright & Co. | |
08.11.16 | Fate Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
15.04.16 | Fate Therapeutics Outperform | BMO Capital Markets | |
11.05.15 | Fate Therapeutics Buy | H.C. Wainwright & Co. |
Werbung
Werbung